80%Confidence
0Views
FDASource
2026-03-26Date
Summary
Temozolomide Capsules recall due to stability testing failures indicates potential degradation issues that could compromise cancer treatment efficacy. This may create temporary shortages and increase scrutiny on Rising Pharma's manufacturing processes.
Actionable: Check Temozolomide inventory and consider alternative suppliers until stability issues are resolved.
AI Confidence: 80%
Data Points
firmRising Pharma Holding, Inc.
classificationClass II
statusOngoing
distributionNationwide within the U.S
productProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now